The Scientific Team at EpiBiologics is responsible for researching and developing innovative antibody-based therapies targeting membrane and extracellular proteins implicated in disease biology. Their work includes protein engineering, molecular biology, and bioinformatics to drive forward the discovery and optimization of novel treatment candidates.
View all